Your generosity through the Emory COVID-19 Impact Fund has allowed Emory to keep our community safe and deepen our understanding of this infectious disease. Our researchers have advanced antiviral medicine like remdesivir, developed fast and accurate virus tests, expanded antibody testing, furthered our understanding of immunity, and have created national guidelines on response protocols.
The COVID-19 Impact Fund has helped keep our health care workers safe with new PPE and equipment, as well as a program to sterilize PPE with vaporized hydrogen peroxide.
Even as the number of cases rise, we enter the new year with hope. Highly effective vaccines are being distributed around the world. Emory played a major role as the nation’s largest trial site for the Moderna mRNA vaccine. Now, that vaccine is being administered to health care workers and essential workers across the country.
“I’ve watched patients, families, friends, and my peers suffer the ravages of COVID-19,” says Kim Bently, Vice President of Operations for Emory Hillandale Hospital. “Getting the vaccine, for me, is the first step in the alleviation of that widespread suffering.”
Thanks to your support, Emory has also helped expand accessibility to testing and care across Georgia, including reopening school-based health centers in underserved communities.
Your ongoing support has carried these efforts through many challenging months. We are now fighting through a massive surge to keep Atlanta and Georgia safe until enough people are vaccinated. We encourage you to hare this message with your network and we hope that you will continue to support Emory’s COVID-19 research and response.